Fintel reports that on January 8, 2025, TD Cowen upgraded their outlook for Cardinal Health (NYSE:CAH) from Hold to Buy.

Cardinal Health (CAH – Research Report) received a Buy rating and a $144.00 price target from TD Cowen analyst Charles Rhyee today. The ...

The Dublin healthcare giant reported $226.8 billion in sales for FY24 that ended June 30, the ninth consecutive year of ...

Cardinal Health Inc. CAH is well-poised for growth, given its long-term supply agreements, diversified product portfolio and strong quarterly earnings. However, the possibility of losing a major ...

Learn more about whether Cardinal Health, Inc. or Fresenius Medical Care AG is a better investment based on AAII's A+ ...

In the most recent trading session, Cardinal Health (CAH) closed at $117.92, indicating a -1.02% shift from the previous trading day.

Fintel reports that on January 7, 2025, Evercore ISI Group upgraded their outlook for Cardinal Health (NYSE:CAH) from In-Line ...

The latest trading day saw Cardinal Health (CAH) settling at $119.63, representing a +0.28% change from its previous close.

Learn more about whether Cardinal Health, Inc. or DaVita Inc. is a better investment based on AAII's A+ Investor grades, ...

The healthcare sector is projected to show significant growth. Here's how the stocks of Cardinal Health, Pediatrix Medical Group and Tenet Healthcare stack up.

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions ...